Tuesday, 30 August 2016

U.S. FDA approves Novartis biosimilar to Amgen's Enbrel

(Reuters) - The U.S. Food and Drug Administration on Tuesday approved Novartis AG's biosimilar version of Amgen Inc's arthritis drug Enbrel.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)